Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Festa

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Cardiovascular Diabetology|September 5, 2015
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide studyRafael Simó, Bruno Guerci, Guntram Schernthaner, et al.
Circulation|December 14, 2005
Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis StudyAnthony J G Hanley, Andrew J Karter, Ken Williams, et al.
Diabetes, Obesity & Metabolism|July 4, 2017
Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM)Simon R Heller, Richard E Pratley, Alan Sinclair, et al.
Diabetes Care|June 29, 2004
Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitusChristine Winzer, Oswald Wagner, Andreas Festa, et al.
Circulation|June 29, 2005
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis StudyAndreas Festa, Ken Williams, Anthony J G Hanley, et al.
Diabetes Care|September 30, 2003
Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?Steven M Haffner, Ralph D'Agostino, Andreas Festa, et al.
Diabetes|September 28, 2004
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis studyAnthony J G Hanley, Ken Williams, Andreas Festa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis StudyNels C Olson, Peter W Callas, Anthony J G Hanley, et al.
Diabetes Technology & Therapeutics|March 8, 2021
Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian Diabetes Patienten Verlaufsdokumentation RegistryTorben Biester, Anke Schwandt, Bettina Heidtmann, et al.
Journal of Diabetes Science and Technology|June 13, 2018
Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes MellitusRichard E Pratley, Julio Rosenstock, Simon R Heller, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Cardiovascular Diabetology|September 5, 2015
Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide studyRafael Simó, Bruno Guerci, Guntram Schernthaner, et al.
Circulation|December 14, 2005
Prediction of type 2 diabetes mellitus with alternative definitions of the metabolic syndrome: the Insulin Resistance Atherosclerosis StudyAnthony J G Hanley, Andrew J Karter, Ken Williams, et al.
Diabetes, Obesity & Metabolism|July 4, 2017
Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM)Simon R Heller, Richard E Pratley, Alan Sinclair, et al.
Diabetes Care|June 29, 2004
Plasma adiponectin, insulin sensitivity, and subclinical inflammation in women with prior gestational diabetes mellitusChristine Winzer, Oswald Wagner, Andreas Festa, et al.
Circulation|June 29, 2005
Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis StudyAndreas Festa, Ken Williams, Anthony J G Hanley, et al.
Diabetes Care|September 30, 2003
Low insulin sensitivity (S(i) = 0) in diabetic and nondiabetic subjects in the insulin resistance atherosclerosis study: is it associated with components of the metabolic syndrome and nontraditional risk factors?Steven M Haffner, Ralph D'Agostino, Andreas Festa, et al.
Diabetes|September 28, 2004
Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis studyAnthony J G Hanley, Ken Williams, Andreas Festa, et al.
The Journal of Clinical Endocrinology and Metabolism|January 13, 2012
Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis StudyNels C Olson, Peter W Callas, Anthony J G Hanley, et al.
Diabetes Technology & Therapeutics|March 8, 2021
Declining Frequency of Acute Complications Associated with Tubeless Insulin Pump Use: Data from 2,911 Patients in the German/Austrian Diabetes Patienten Verlaufsdokumentation RegistryTorben Biester, Anke Schwandt, Bettina Heidtmann, et al.
Journal of Diabetes Science and Technology|June 13, 2018
Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes MellitusRichard E Pratley, Julio Rosenstock, Simon R Heller, et al.
Pageof 5